Get started
Author

Richard Max Miller

Observed names: R. Miller, Richard M. Miller
Observed institutions: Creighton University, Mayo Clinic, University of Cambridge, Mayo Clinic in Arizona, Mayo Clinic Hospital, HonorHealth
ORCID: 0000-0002-4936-2243
Observed ORCID: 0000-0002-4936-2243
OpenAlex ID: A5083219183
Management of young onset colorectal cancer: divergent practice in the East of England
2011 · L. Anning, N. Koo, et al. · Colorectal Disease · 9
Redefining Upfront Resectable Pancreatic Ductal Adenocarcinoma: Should Vein Abutment Matter?
2026 · Po Hong Tan, Cornelius A. Thiels, et al. · Journal of the National Comprehensive Cancer Network · 1
Corrigendum to “Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer” [Redox Biol. 88 (2025) 103895]
2026 · Gayle S. Jameson, S. Danielle LeGrand, et al. · Redox Biology
Longitudinal assessment of recurrence after open versus laparoscopic versus robotic inguinal hernia repair in 272,475 patients
2026 · Hoe Yan Hor, Melody Pi Yin Tu, et al. · Surgical Endoscopy
Su1859 UPFRONT RESECTION VS NEOADJUVANT CHEMOTHERAPY FOR PATIENT WITH UPFRONT RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA AND LOW CARBOHYDRATE ANTIGEN 19-9 LEVELS
2026 · Po Hong Tan, Dillon C. Cheung, et al. · Gastrointestinal Endoscopy
Su1859 UPFRONT RESECTION VS NEOADJUVANT CHEMOTHERAPY FOR PATIENT WITH UPFRONT RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA AND LOW CARBOHYDRATE ANTIGEN 19-9 LEVELS
2026 · Po Hong Tan, Dillon C. Cheung, et al. · Gastroenterology
Su1925 MURAL NODULE FEATURES ON EUS AS PREDICTOR OF MALIGNANCY IN IPMN: MULTI-CENTER RETROSPECTIVE COHORT ANALYSIS OF PATHOLOGY CONFIRMED CASES
2026 · Hyun Jae Kim, FNU Murlidhar, et al. · Gastrointestinal Endoscopy
Su1925 MURAL NODULE FEATURES ON EUS AS PREDICTOR OF MALIGNANCY IN IPMN: MULTI-CENTER RETROSPECTIVE COHORT ANALYSIS OF PATHOLOGY CONFIRMED CASES
2026 · Hyun Jae Kim, FNU Murlidhar, et al. · Gastroenterology
De‐Escalating Surgery for 1–2 cm Appendiceal Neuroendocrine Tumors: A North American Multi‐Center Analysis
2026 · Richard Max Miller, Po Hong Tan, et al. · Journal of Surgical Oncology
PDF
HSR26-203: Financial Burden of Ocular Melanoma: A 7 Year Analysis of Trends Influencing Patient Charges and Costs to Hospitals in the Treatment of Ocular Melanoma
2026 · William Ender Graham, Richard Max Miller, et al. · Journal of the National Comprehensive Cancer Network
HSR26-199: Socioeconomic, Geographic, and Insurance-Related Disparities in Survival and Treatment Outcomes for Ocular Melanoma: A 21-Year National Inpatient Cohort Study
2026 · Richard Max Miller, William E. Graham, et al. · Journal of the National Comprehensive Cancer Network
68: Developtment and External Validation of a Predictive Model for Nodal Metastsases in Appendiceal Cancer – Who Needs Right Hemicolectomy?
2025 · Po Hong Tan, Richard Max Miller, et al. · Gastroenterology
Works count: 12
Citation count: 10
H-index: 1
I10-index:
Year
Topic
Type